| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |